Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Tatva Chintan Pharma Chem's current ratio for the quarter that ended in Jun. 2026 was 0.00.
Tatva Chintan Pharma Chem has a current ratio of 0.00. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Tatva Chintan Pharma Chem has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Tatva Chintan Pharma Chem's Current Ratio or its related term are showing as below:
BOM:543321'
s Current Ratio Range Over the Past 10 Years
Min: 1.31 Med: 1.98 Max: 3.96
Current: 1.64
During the past 8 years, Tatva Chintan Pharma Chem's highest Current Ratio was 3.96. The lowest was 1.31. And the median was 1.98.
BOM:543321's Current Ratio is ranked worse than 59.88% of 1605
companies
in the Chemicals industry
Industry Median: 1.89
vs BOM:543321: 1.64
Tatva Chintan Pharma Chem (BOM:543321) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Tatva Chintan Pharma Chem Current Ratio Related Terms
Tatva Chintan Pharma Chem Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543321 vs LIN, SHW, ECL: Current Ratio Comparison
For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tatva Chintan Pharma Chem Current Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Current Ratio distribution charts can be found below:
* The bar in red indicates where Tatva Chintan Pharma Chem's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tatva Chintan Pharma Chem (BOM:543321) has a Current Ratio of 0.00 as of Jun. 2026. Over the past decade, Tatva Chintan Pharma Chem's Current Ratio has ranged from 1.31 to 3.96. According to the industry distribution chart, Tatva Chintan Pharma Chem ranks #961 out of 1605 companies in the Chemicals industry, placing it in the top 59.9%.
Is Tatva Chintan Pharma Chem's Current Ratio too high?
Tatva Chintan Pharma Chem's current Current Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 1.31 to a high of 3.96. Based on the distribution chart, Tatva Chintan Pharma Chem ranks #961 out of 1605 companies in the Chemicals industry, which is below the industry midpoint. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Current Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, Tatva Chintan Pharma Chem ranks #961 out of 1605 companies for Current Ratio. This places Tatva Chintan Pharma Chem in the lower half of its industry. The industry median Current Ratio is 1.89. Historically, Tatva Chintan Pharma Chem's own Current Ratio has ranged from 1.31 to 3.96 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Chemicals company?
The median Current Ratio among Chemicals companies is 1.89, based on 1,605 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median Current Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tatva Chintan Pharma Chem's current Current Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (BOM:543321) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,496.82, compared to a current price of ₹1,726.45 — trading 15.3% above its estimated fair value. The current Current Ratio is 0.00. Tatva Chintan Pharma Chem's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (BOM:543321), the current Current Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tatva Chintan Pharma Chem (BOM:543321) Overvalued in 2026?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be overvalued.
The current stock price of ₹1,726.45 is trading 15.3% above its estimated GF Value™ of ₹1,496.82.
GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Overvalued.
Key valuation signals for BOM:543321:
Current Ratio: 0.00
GF Value™: ₹1,496.82 vs. price of ₹1,726.45 (15.3% above fair value)
No single metric tells the full story. See the BOM:543321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
82GF Score
Get the complete analysis for BOM:543321
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543321 has been successfully added to your 
